Increased endothelial nitric oxide synthase activity in the hyperemic vessels of portal hypertensive rats

Journal of Hepatology

Volumn 25, Issue 3, 1996, Pages 370-378

  Cahill, Paul A ^a,b   Redmond, Eileen M ^a   Hodges, Robert ^a   Zhang, Shuangmin ^a   Sitzmann, James V ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Nitric oxide synthase; Portal hypertension; Splanchnic hyperemia

Indexed keywords

CYCLIC GMP; NITRIC OXIDE SYNTHASE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; HYPEREMIA; IMMUNOBLOTTING; MALE; MESENTERIC ARTERY; NONHUMAN; PORTAL HYPERTENSION; PORTAL VEIN; PRIORITY JOURNAL; RAT; THORACIC AORTA;

EID: 0030248313     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(96)80124-3     Document Type: Article

References (58)

1. Ballet F. Hepatic circulation: potential for therapeutic intervention. Pharmacol Ther. 47:1990;281-328.
2. Cahill PA, Wu Y, Sitzmann JV. Altered adenylyl cyclase activities and G-protein abnormalities in portal hypertensive rabbits. J Clin Invest. 93:1994;2691-2700.
3. Reichen J. Liver function and pharmacological considerations in the pathogenesis and treatment of portal hypertension. Hepatology. 11:1990;1066-1078.
4. Vorobioff J, Bredfeldt JE, Groszmann RJ. Hyperdynamic circulation in portal hypertensive rat model: a primary factor for maintenance of chronic portal hypertension. Am J Physiol. 244:1983;G52-G27.
5. Castro A, Jimenez W, Claria J., Martinez JM, Bosch J, Arroyo AV, Piulats J, Rivera P, Bosch J. Impaired responsiveness to angiotensin II experimental cirrhosis: role of nitric oxide. Hepatology. 18:1993;367-372.
6. Kamath S, Hunter LW, Tyce GM, Miller VM, Rorie DK. Hyporesponsiveness to norepinephrine in the portal vein of portal hypertensive rats is partially mediated by nitric oxide. Hepatology. 18:1993;281A.
7. Kamath S, Hunter LW, Tyce GM, Miller VM, Rorie DK. Hyporesponsiveness to norepinephrine in the portal vein of portal hypertensive rats is partially mediated by nitric oxide. Hepatology. 18:1993;900.
8. Kiel JW, Pitts L, Benoit JN, Granger DN, Shepherd AP. Reduced vascular sensitivity to norepinephrine in portal hypertensive rats. Am J Physiol. 248:1985;G192-G195.
9. Lee F.-Y., Albillos A, Colombato LA, Groszmann RJ. The role of nitric oxide in the vascular hyporesponsiveness to methoxamine in portal hypertensive rats. Hepatology. 16:1992;1043-1048.
10. G-nitro-L-arginine administration corrects peripheral vasodilation and systemic capillary hypotension and ameliorates plasma volume expansion and sodium retention in portal hypertensive rats. Hepatology. 17:1993;85-90.
11. Sieber CC, Groszmann RJ. Nitric oxide mediates hyporeactivity to vasopressors in mesenteric vessels of portal hypertensive rats. Gastroenterology. 103:1992;235-239.
12. Sitzmann JV, Li SS, Lin PW. Prostacyclin mediates splanchnic vascular response to norepinephrine in portal hypertension. J Surg Res. 47:1989;208-211.
13. Benoit JN, Zimmerman B, Premen AJ, Go VLW, Granger DN. Role of glucagon in splanchnic hyperemia of chronic portal hypertension. Am J Physiol. 251:1986;G674-G677.
14. Cahill PA, Foster CL, Redmond EM, Gingalewski C, Wu Y, Sitzmann JV. Enhanced nitric oxide synthase activity in portal hypertensive rabbits. Hepatology. 22:1995;598-606.
15. Sitzmann JV, Bulkley GB, Mitchell M, Campbell K. Role of prostacyclin in the splanchnic hyperemia contributing to portal hypertension. Ann Surg. 209:1988;322-327.
16. Wu Y, Burns RC, Sitzmann JV. Effects of nitric oxide and cycloxygenase inhibition on splanchnic hemodynamics in portal hypertension. Hepatology. 18:1993;1416-1421.
17. Buga GM, Gold ME, Fukuto JM, Ignarro LJ. Shear stress-induced release of nitric oxide from endothelial cells grown on beads. Hypertension. 17:1991;187-193.
18. Moncada SR, Palmer M, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacology Rev. 43:1991;109-141.
19. Ohno M, Gibbons GH, Dzau VJ, Cooke JP. Shear stress elevated endothelial cGMP, role of potassium channel and G-protein coupling. Circulation. 88:1994;193-197.
20. Rubanyi GM, Romero JC, Vanhoutte PM. Flow-induced release of endothelium-derived relaxing factor. Am J Physiol. 255:1986;H1145-H1149.
21. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:1992;3051-3064.
22. Bredt DS, Huang PM, Glatt GE, Lowenstein C, Reed RR, Snyder S. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature. 351:1991;714-718.
23. Bredt DS, Snyder SH. Isolation of nitric oxide synthase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA. 87:1990;682-685.
24. Iida S, Ohshima H, Oguchi S, Hata T, Suzuki H, Kawasaki H, Esum H. Identification of inducible calmodulin-dependent nitric oxide synthase in the liver of rats. J Biol Chem. 267:1992;25385-25388.
25. Radomski MW, Palmer RMJ, Moncada S. Glucocorticoids inhibit the expression of an inducible, but not constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci USA. 87:1990;10043-10047.
26. Xie Q.-W., Cho HJ, Calaycay J, Munford RA, Swiderek M, Lee TD, Ding A, Nathan C. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science. 256:1992;225-228.
27. Lamas S, Marsden PA, Li GK, Tempst P, Michel T. Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc Natl Acad Sci USA. 89:1992;6348-6352.
28. Schmidt HHW, Lohmann SM, Walter U. The nitric oxide and cGMP signal transduction system: regulation and mechanism of action. Biochim Biophys Acta. 1178:1993;153-175.
29. Wu Y, Li SS, Campbell KA, Sitzmann JV. Modulation of splanchnic vascular sensitivity to angiotensin II. Surgery. 110:1991;162-168.
30. Iwata F, Joh I, Kawai K, Itoh M. Role of EDRF in splanchnic blood flow of normal and chronic portal hypertensive rats. Am J Physiol. 263:1992;G149-G154.
31. Pizcueta MP, Pique JM, Bosch J, Whittle BJR, Moncada S. Effects of inhibiting nitric oxide biosynthesis on the systemic and splanchnic circulation of rats with portal hypertension. Br J Pharmacol. 105:1992;184-190.
32. Bradford MM. A rapid and sensitive method for quantification of microgram quantities of protein utilizing the principle of protein dye binding. Ann Biochem. 72:1976;248-254.
33. 15 mole level. Anal Biochem. 70:1976;195-202.
34. Cahill PA, Redmond EM, Foster C, Sitzmann JV. Nitric oxide regulates angiotensin II receptors in vascular smooth muscle cells. Eur J Pharmacol. 288:1995;219-229.
35. Redmond EM, Cahill PA, Hodges R, Zhang S, Sitzmann JV. Regulation of endothelin receptors by nitric oxide in rat vascular smooth muscle cells. J Cell Physiol. 1996;. in press.
36. Cahill PA, Redmond EM, Keenan AK. Vascular atrial natriuretic factor receptor subtypes are not independently regulated by atrial peptides. J Biol Chem. 265:1990;21896-21906.
37. 15N]nitrate in biological fluids. Anal Biochem. 126:1982;131-138.
38. Sogni P, Moreau R, Oshuga H, Cailmail S, Olerti F, Hadengue A, Pussard E, Lebrec D. Evidence of normal nitric oxide-mediated vasodilation in conscious rats with cirrhosis. Hepatology. 16:1992;980-983.
39. Nathan C. Nitric oxide and biopterin: a study in chiaroscuro. J Clin Invest. 93:1994;1875-1876.
40. Sessa WC, Barber CM, Lynch KR. Mutation of N-myristoylation site converts endothelial nitric oxide synthase from a membrane to a cytosolic protein. Circ Res. 72:1993;921-925.
41. Werner-Felmayer G, Wener ER, Fuchs D, Hausen A, Reibnegger G, Schmidt K, Weiss G, Wachter H. Pteridine biosynthesis in human endothelial cells. Impact on nitric oxide-mediated formation of cGMP. J Biol Chem. 268:1993;1842-1846.
42. Rosenkranz-Weiss P, Sessa WC, Milstein S, Kaufman S, Watson K, Pober JS. Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells: elevations in tetrahydrobiopterin levels enhance endothelial nitric oxide synthase specific activity. J Clin Invest. 93:1994;2236-2243.
43. Johansson B. Structural and functional changes in rat portal vein after experimental portal hypertension. Acta Physiol Scand. 98:1976;381-383.
44. Arnal JF, Yamin J, Sayegh H, Dockery S, Harrison DG. Regulation of endothelial nitric oxide synthase mRNA, protein and activity during cell growth. Circulation. 90:1994;A2178.
45. Lamontagne D, Pohl U, Busse R. Mechanical deformation of vessel wall and shear stress determine the basal release of endothelium relaxing factor in the intact rabbit coronary vascular bed. Circ Res. 70:1992;123-130.
46. Feletou M, Hoeffner U, Vanhoutte PM. Endothelium-dependent relaxing factors do not affect the smooth muscle of portal-mesenteric veins. Blood Vessels. 26:1989;21-32.
47. Suga T, Itoh H, Shimomura A, Kusagawa M, Ito M, Takase K, Konishi T, Nakano T. Comparison of the effects of various a vasodilators on the rat portal vein and mesenteric artery. Eur J Pharmacol. 242:1993;129-136.
48. Lopez-Talevera JC, Merrill W, Groszmann RJ. Treatment with anti-tumor necrosis factor-α polyclonal antibodies prevents the development of the hyperdynamic circulation and reduces portal pressure in portal hypertensive rats. Hepatology. 18:1993;140A.
49. Lopez-Talevera JC, Merrill W, Groszmann RJ. Treatment with anti-tumor necrosis factor-α polyclonal antibodies prevents the development of the hyperdynamic circulation and reduces portal pressure in portal hypertensive rats. Hepatology. 18:1993;336.
50. Palmer RMJ. The discovery of nitric oxide in the vessel wall: A unifying concept in the pathogenesis of sepsis. Arch Surg. 128:1993;396-401.
51. Michielsen PP, Ramon AM, Van Assche RJ, Pelckmans PA, Van Maercke WM. Endotoxinemia in portal hypertension. Hepatology. 18:1993;284A.
52. Michielsen PP, Ramon AM, Van Assche RJ, Pelckmans PA, Van Maercke WM. Endotoxinemia in portal hypertension. Hepatology. 18:1993;909.
53. Fernandez M, Pagan JC, Casadevall M, Bernadich C, Piera C, Whittle B, Pique JM, Bosch J, Rodes J. Evidence for a role for Inducible Nitric Oxide Synthase in the hyperdynamic circulation of portal hypertensive rats. Gastroenterology. 108:1995;1487-1495.
54. Joh T, Granger N, Benoit J. Endogenous vasoconstrictor tone in intestine of normal and portal hypertensive rats. Am J Physiol. 264:1993;H171-H177.
55. Brodde O.-E., Michel MC. Adrenergic receptors and their signal transduction mechanisms in hypertension. J Hypertens. 10:1992;S133-S145. (suppl 7).
56. Flavahan NA, Vanhoutte PM. G-proteins and endothelial responses. Blood Vessels. 27:1990;218-219.
57. Flavahan NA, Shimokawa H, Vanhoutte PM. Pertussis toxin inhibits endothelium-dependent relaxations evoked by certain endothelial activators in porcine coronary arteries. J Physiol. 408:1989;549-561.
58. Ros J, Jimenez W, Lamas L, Claria J, Arroyo V, Rivera F, Rodes J. Nitric oxide production in arterial vessels of cirrhotic rats. Hepatology. 21:1995;554-560.